September 28, 2010 — An agreement has been reached to begin joint development of a world-first novel proton beam therapy (PBT) system for cancer treatment under Japan’s FIRST program. Treatment will start in 2014.
If you enjoy this content, please share it with a colleague
September 28, 2010 — In one of the first studies to focus exclusively on the outcomes after treatment for patients with high-risk prostate cancer, researchers have found that surgery provides high survival rates.
September 28, 2010 – Virtual Radiologic (vRad), a national radiology practice and leader in the development of radiologist workflow technology, and NightHawk Radiology, a leading provider of radiology solutions to radiology groups across the United States, announced they have entered into a definitive agreement under which vRad will acquire all of the outstanding common stock of NightHawk Radiol
September 28, 2010 – A fully automatic, all-in-one ultrasound cleansing and disinfection system, the Mides Transesophageal (TEE)-Care, offers ease-of-use and safe handling. It was recently introduced in Europe.
September 28, 2010 – Physicians can now determine whether a patient needs to have cardiac radionuclide imaging (RNI) by using a new smartphone app. The app, which is available for free on iPhone, BlackBerry and Android phones, gives physicians access to published criteria used to assess the need for RNI.
September 27, 2010 — Several products for image guidance, digital control, field shaping and respiratory motion management for radiation oncology were presented at the 2010 meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO), Sept. 12-16, in Barcelona, Spain.
September 27, 2010 – A new lightweight, wireless and cassette-sized digital radiography system is available, with a detector that has the same dimensions as a 14- by 17-inch ISO4090-compliant film cassette. This enables it to fit an existing wall-stand or table bucky tray without modifications.
September 27, 2010 — The Radiological Devices Panel of the U.S. Food and Drug Administration (FDA) unanimously voted that Hologic Inc.’s pre-market approval (PMA) demonstrated both the effectiveness and safety of the company’s Selenia Dimensions 3-D digital mammography tomosynthesis system. The panel also voted in favor that the benefits of this new technology outweigh the risks.
